| Quick Studies
Thomas W. Abrams, PhD, associate professor, Departments of Pharmacology & Experimental Therapeutics and Anesthesiology, has been awarded a five-year $1,544,872 grant to study “Non Associative and Associative Neuroplasticity.”
Laure Aurelian, PhD, professor, Departments of Pharmacology & Experimental Therapeutics and Microbiology & Immunology, was issued a patent for the “Vaccine Composition for Herpes Simplex Virus and Method of Using” invention.
Robert J. Hickey, PhD, associate professor, and Linda H. Malkas, PhD, associate professor, Department of Pharmacology & Experimental Therapeutics, have received a patent for their “Assay for Measuring the Activity and Fidelity of DNA Replication and Kit Therefor” technology.
Marcia C. Javitt, MD, professor, Department of Diagnostic Radiology & Nuclear Medicine, was recently selected as a recipient of the 2000 Radiology journal Editor’s Recognition Award for reviewing with “Distinction.”
Herbert A. Kushner, MD, associate professor, Department of Medicine, received the Samuel Asper Award for Excellence in Internal Medicine, presented by the Maryland Chapter of American College of Physicians during its annual meeting in December.
Alan R. Shuldiner, MD, professor and Soren Snitker, MD, PhD, assistant professor, Department of Medicine, were awarded a three-year $1,256,100 grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. They will study the pharmacogenetics of thiazolidinediones, commonly used medications for the treatment of type 2 diabetes.
Jordan E. Warnick, PhD, professor, Department of Pharmacology & Experimental Therapeutics, and assistant dean, Student Education and Research, was awarded a Dr. Martin Luther King, Jr. Diversity Recognition Award at the University of Maryland Baltimore’s Dr. Martin Luther King, Jr. Commemoration held on January 22.
|  |
New Assistant Dean for Finance Appointed

Effective February 1, John Galleazzi, MBA, the former senior administrator for the Department of Pathology, took on a new role as assistant dean for finance, and will function as the chief financial officer for the School of Medicine. Mr. Galleazzi will have direct responsibility for the Division of Finance within the dean’s office, which includes financial management of all dean’s funds. In addition, he will have financial oversight responsibility for the entire School of Medicine, and will help to facilitate full implementation of the School’s mission-based management initiative.
Mr. Galleazzi brings an extensive background in health care management. His former position in the Department of Pathology included assisting the chairman in turning around a department with a significant deficit into one that is now making positive financial contributions to the School of Medicine.
Prior to joining the Department of Pathology in 1999, Mr. Galleazzi held a number of senior positions, including administrator of Northwestern Medical Faculty Foundation in Chicago, IL; vice president and general manager of Primedical Physician Care Centers in St. Louis, MO; vice president of St. Johns Mercy Medical Center in St. Louis, MO; and assistant administrator of St. Joseph’s Hospital in Kirkwood, MO. His experience in health care administration includes financial and operational management, multi-specialty group practice, hospital department management, and information systems.
“John has the innovation, skills and experience to help the School of Medicine reach its financial goals,” comments Gregory F. Handlir, MBA, associate dean for resource management. “Not only does he have the financial background, but because he worked in the Department of Pathology, John also has the academic and environmental understanding of how things operate here at the School of Medicine. We are glad to have John on our team.”
Mr. Galleazzi received his master’s degree in business administration from St. Louis University, and is a member of the Medical Group Management Association and the Association of Academic Orthopaedic Administrators.
|